Technologies available for licensing, investment, joint ventures and R&D contracts in Ukraine, Azerbaijan, Georgia, Moldova, Uzbekistan

Frontpage Slideshow (version 2.0.0) - Copyright © 2006-2008 by JoomlaWorks

Google Translate

Patenting Information

Tag Cloud



Free counters!

Home Biotechnologies Antitumor autologous vaccine

Antitumor autologous vaccine

Areas of Application.

For applied medicine use, for cancer biotherapy. Integrating the antitumor autovaccine (AAV) into therapy of oncology patients provides a means of prevention of development of metastasis and disease recurrence, increase of the survival rates of such patients and improvement of their quality of life.

Technical Specification (Specification).

The vaccine includes biotechnologically-modified (through the use of metabolism products of Bacillus subtilis B-7025) tumor antigens of autologous tumor.

Advantages.

There is no analogues of AAV. It is suitable for the treatment of patients with various tumors. Vaccine was tested in some oncological clinics in Ukraine and is prepared to be included into standards of care for personalized treatment of oncology patients. The AAV is well tolerated, it is not toxic and easy to use.

Stage of Development.

Suggestion for commercialization AAV went through preclinical and some clinical trials. We are looking for industrial partners for conducting additional clinical trials and licensing.

IPR protection

Ukrainian patents and secret know-how.

Contacts

Pyatchanina Tatiana V 
Organization: RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology NAS of Ukraine.
+38044-259-01-67
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Add comment


Security code
Refresh

For additional technologies go to: http://www.stcu.int